Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term.

Q4 2024 Management View CEO Randall Lipps highlighted that Omnicell exceeded bookings guidance for 2024, driven by strong connected devices demand. He emphasized the traction of the XT Amplify program ...

The Greenwich, Conn.-based less-than-truckload carrier posted net income of $76 million, compared with $58 million during the ...

The SEC has announced increased revenue distributions for each of its members following the 2023-24 fiscal year.

NIntendo's Switch handheld-and-console hybrid family of hardware achieved more than 150 million unit sales, 1.3 billion games ...

Revenues in the Transportation Fund underperformed their $25.0 million December consensus target by $0.17 million, or 0.7%, ...

Company executives view 2024 as a strategic year of investment, positioning BetMGM for profitability in 2025. The company’s ...

Julius Berger has reported a pre-tax profit of N29.5 billion for the full year ending December 31, 2024, as outlined ...